Baird analyst Mark Altschwager maintains Allbirds (NASDAQ:BIRD) with a Outperform and lowers the price target from $8 to $7.
Catalent To Hold Business Update Call Related To Delay Of Q3 2023 Results On Friday, May 19, 2023 at 8:15 a.m. ET And Receives NYSE Notice Regarding Late Form 10-Q Filing
Catalent, Inc. ("Catalent" or the "Company") (NYSE:CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that, in light of the
